• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性粒细胞白血病病程中发生的纯红细胞再生障碍]

[Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].

作者信息

Yasuyama Masako, Kawauchi Kiyotaka, Takei Kazuhiro, Ogasawara Toshie, Ohkawa Shinichiro

机构信息

Department of Medicine, Tokyo Women's Medical University Daini Hospital.

出版信息

Rinsho Ketsueki. 2004 Jan;45(1):66-71.

PMID:14999937
Abstract

The patient was a 47-year-old man who was diagnosed in 1989 as having chronic myelogenous leukemia (CML). He had been treated with interferon-alpha (IFN-alpha) and hydroxyurea. In August 1999, he was admitted to our hospital for examination of severe anemia and increased platelet count. On admission, his hemoglobin level was 6.3 g/dl, reticulocyte count was 0.7%, WBC count was 5,100/microliter, and platelet count was 57.3 x 10(4)/microliter. Bone marrow aspiration showed myeloid hyperplasia and near absence of erythroblasts. Bone marrow karyotype analysis showed a Ph chromosome with additional abnormalities. Pure red cell aplasia (PRCA) with accelerated-phase CML was considered. The IFN-alpha therapy was discontinued. Hydroxyurea at an increased dosage was effective in controlling the CML. In contrast, administration of cyclosporin A was not effective for the PRCA. The patient's condition was later complicated by acute hepatitis C virus infection. The IFN-alpha was restarted to control the CML and hepatitis. The patient remained erythroblastopenic and transfusion-dependent for more than 2 years. Association of CML and PRCA is rare. We discuss the mechanisms underlying PRCA occurring during the course of CML.

摘要

该患者为一名47岁男性,1989年被诊断为慢性粒细胞白血病(CML)。他曾接受过α干扰素(IFN-α)和羟基脲治疗。1999年8月,他因严重贫血和血小板计数增加入院检查。入院时,他的血红蛋白水平为6.3 g/dl,网织红细胞计数为0.7%,白细胞计数为5100/微升,血小板计数为57.3×10⁴/微升。骨髓穿刺显示骨髓增生,几乎没有成红细胞。骨髓核型分析显示有费城染色体及其他异常。考虑为慢性粒细胞白血病加速期合并纯红细胞再生障碍性贫血(PRCA)。停用α干扰素治疗。增加剂量的羟基脲对控制慢性粒细胞白血病有效。相比之下,环孢素A对PRCA无效。该患者后来并发急性丙型肝炎病毒感染。重新开始使用α干扰素以控制慢性粒细胞白血病和肝炎。该患者持续成红细胞缺乏且依赖输血超过2年。慢性粒细胞白血病与PRCA的关联罕见。我们讨论了慢性粒细胞白血病病程中发生PRCA的潜在机制。

相似文献

1
[Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].[慢性粒细胞白血病病程中发生的纯红细胞再生障碍]
Rinsho Ketsueki. 2004 Jan;45(1):66-71.
2
[Myositis caused by hydroxyurea in a patient with chronic myelogenous leukemia].
Rinsho Ketsueki. 1998 Sep;39(9):676-9.
3
[One-year remission of chronic myelogenous leukemia (CML) after discontinuation of interferon-alpha].
Rinsho Ketsueki. 1990 Jul;31(7):1013-6.
4
Philadelphia negative, Bcr-Abl positive chronic myeloid leukemia associated with pure red cell aplasia.费城染色体阴性、Bcr-Abl阳性慢性髓性白血病伴纯红细胞再生障碍。
J Exp Clin Cancer Res. 2003 Jun;22(2):341-2.
5
[Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
Rinsho Ketsueki. 1998 Apr;39(4):302-7.
6
[Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
Rinsho Ketsueki. 1989 Mar;30(3):400-3.
7
[Chronic myelogenous leukemia following therapy for pineal germinoma].松果体生殖细胞瘤治疗后发生的慢性粒细胞白血病
Rinsho Ketsueki. 2004 Jan;45(1):72-4.
8
Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.羟基脲治疗的慢性粒细胞白血病患者并发白塞病:一例报告及文献复习
Am J Hematol. 2001 Jan;66(1):57-8. doi: 10.1002/1096-8652(200101)66:1<57::AID-AJH1010>3.0.CO;2-3.
9
Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to re-introduction of cyclosporin.
Bone Marrow Transplant. 2004 Feb;33(4):459-61. doi: 10.1038/sj.bmt.1704366.
10
[Successful treatment of combined interferon-alpha and hydroxycarbamide for chronic myelogenous leukemia following therapy for malignant lymphoma].[恶性淋巴瘤治疗后α-干扰素与羟基脲联合治疗慢性粒细胞白血病成功]
Rinsho Ketsueki. 1996 Sep;37(9):853-7.